D-0075-2018 Class III Terminated

Recalled by Genzyme Corporation — Northborough, MA

FDA drug recall D-0075-2018 was initiated by Genzyme Corporation on Oct 12, 2017 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert. The recall status is terminated (terminated Sep 10, 2020). Affected quantity: 9,343 single dose vials.

Recall details

Product Type
Drugs
Report Date
Nov 22, 2017
Initiation Date
Oct 12, 2017
Termination Date
Sep 10, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,343 single dose vials

Product description

Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.

Reason for recall

Labeling: Incorrect or Missing Package Insert.

Distribution pattern

Nationwide

Code information

Lot #: K5006Y01; Exp. 08/31/18 Lot #: K5006Y03; Exp. 08/31/18 Lot #: K6001Y01; Exp. 03/31/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0075-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Genzyme Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0075-2018. Report a data issue: hello@regdatalab.com.